Related references
Note: Only part of the references are listed.Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human
Lisa Andzinski et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
New horizons in tumor microenvironment biology: challenges and opportunities
Fei Chen et al.
BMC MEDICINE (2015)
Cell Based Drug Delivery: Micrococcus luteus Loaded Neutrophils as Chlorhexidine Delivery Vehicles in a Mouse Model of Liver Abscesses in Cattle
Sebastian O. Wendel et al.
PLOS ONE (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
Saar Gill et al.
IMMUNOLOGICAL REVIEWS (2015)
Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
Jeffrey W. Leong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
Sonia Guedan et al.
BLOOD (2014)
New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia
Marion Subklewe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Macrophages inhibit human osteosarcoma cell growth after activation with the bacterial cell wall derivative liposomal muramyl tripeptide in combination with interferon-γ
Jens H. W. Pahl et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
Tobias Bald et al.
NATURE (2014)
Macrophages Mediate a Switch between Canonical and Non-Canonical Wnt Pathways in Canine Mammary Tumors
Magdalena Krol et al.
PLOS ONE (2014)
CSF-1R as an inhibitor of apoptosis and promoter of proliferation, migration and invasion of canine mammary cancer cells
Magdalena Krol et al.
BMC VETERINARY RESEARCH (2013)
Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
Munitta Muthana et al.
CANCER RESEARCH (2013)
NK cell-based immunotherapy for malignant diseases
Min Cheng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
Diverse novel functions of neutrophils in immunity, inflammation, and beyond
Attila Mocsai
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia
Ali Memarian et al.
TUMOR BIOLOGY (2013)
Clinical implications of co-inhibitory molecule expression in the tumor microenvironment for DC vaccination: a game of stop and go
Angela Vasaturo et al.
FRONTIERS IN IMMUNOLOGY (2013)
Retargeting NK-92 cells by means of CD19-and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
Laurent Boissel et al.
ONCOIMMUNOLOGY (2013)
CLINICAL TRIAL EVALUATING DC/AML FUSION CELL VACCINATION ALONE AND IN CONJUNCTION WITH PD-I BLOCKADE IN AML PATIENTS WHO ACHIEVE A CHEMOTHERAPY-INDUCED REMISSION
J. Rosenblatt et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention
Wieger J. Norde et al.
BLOOD (2012)
CD200R signaling in tumor tolerance and inflammation: A tricky balance
Tomasz F. Rygiel et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Third generation dendritic cell vaccines for tumor immunotherapy
Bernhard Frankenberger et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors
Jing Ni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions
Kevin J. Curran et al.
JOURNAL OF GENE MEDICINE (2012)
Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL
Goodwin Jinesh G et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma
Gwi-Moon Seo et al.
MOLECULAR BIOLOGY REPORTS (2012)
Expression of CD200 on AML blasts directly suppresses memory T-cell function
S. J. Coles et al.
LEUKEMIA (2012)
Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells
S. J. Coles et al.
LEUKEMIA (2012)
Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia
S. Anguille et al.
LEUKEMIA (2012)
CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor
T. P. Rygiel et al.
ONCOGENE (2012)
CD86 and IL-12p70 Are Key Players for T Helper 1 Polarization and Natural Killer Cell Activation by Toll-Like Receptor-Induced Dendritic Cells
Felix S. Lichtenegger et al.
PLOS ONE (2012)
Interleukin-15-Induced CD56+ Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
Sebastien Anguille et al.
PLOS ONE (2012)
CD200 Receptor Controls Sex-Specific TLR7 Responses to Viral Infection
Guruswamy Karnam et al.
PLOS PATHOGENS (2012)
Trial watch Dendritic cell-based interventions for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
The determinants of tumour immunogenicity
Thomas Blankenstein et al.
NATURE REVIEWS CANCER (2012)
Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation
Erin M. Bekes et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors
Peter Lang et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2011)
Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors
Munitta Muthana et al.
CANCER RESEARCH (2011)
TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice
Abigail F. Welford et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
S. J. Coles et al.
LEUKEMIA (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells
Willemijn Hobo et al.
BLOOD (2010)
Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia
Qing Zhou et al.
BLOOD (2010)
Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice
Reginald M. Gorczynski et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
Magda Stumpfova et al.
CANCER RESEARCH (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Genotoxic effects of neutrophils and hypochlorous acid
Nejla Gungor et al.
MUTAGENESIS (2010)
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth
A. McGarry Houghton et al.
NATURE MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
TLR3-Stimulated Dendritic Cells Up-regulate B7-H1 Expression and Influence the Magnitude of CD8 T Cell Responses to Tumor Vaccination
Vesna Pulko et al.
JOURNAL OF IMMUNOLOGY (2009)
Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
Sebastien Anguille et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
The involvement of granulocytes in spontaneous regression of Walker 256 carcinoma
Morana Jaganjac et al.
CANCER LETTERS (2008)
Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma
Che-Hsin Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
IFN-α skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo
Claudia Papewalis et al.
JOURNAL OF IMMUNOLOGY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL
Peter Dubsky et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
CD200 expression on tumor cells suppresses antitumor immunity: New approaches to cancer immunotherapy
Anke Kretz-Rommel et al.
JOURNAL OF IMMUNOLOGY (2007)
DC-based cancer vaccines
Eli Gilboa
JOURNAL OF CLINICAL INVESTIGATION (2007)
Antibodies, Fc receptors and cancer
Falk Nimmerjahn et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
Neutrophil granulocytes are required for effective Bacillus Calmette-Guerin immunotherapy of bladder cancer and orchestrate local immune responses
Henrik Suttmann et al.
CANCER RESEARCH (2006)
Controversy - Fighting cancer with oncolytic viruses
Y Chernajovsky et al.
BRITISH MEDICAL JOURNAL (2006)
The effect of a therapeutic dendritic cell-based cancer vaccination depends on the blockage of CTLA-4 signaling
Ö Met et al.
CANCER LETTERS (2006)
Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment
HB Acuff et al.
CANCER RESEARCH (2006)
Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model
FJ Hernandez-Ilizaliturri et al.
LEUKEMIA & LYMPHOMA (2005)
Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells
A Curti et al.
EXPERIMENTAL HEMATOLOGY (2005)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Breast cancer cells stimulate neutrophils to produce oncostatin M: Potential implications for tumor progression
MM Queen et al.
CANCER RESEARCH (2005)
Cancer immunotherapy based on killing of Salmonella-infected tumor cells
F Avogadri et al.
CANCER RESEARCH (2005)
Dendritic-cell-based therapeutic vaccination against cancer
FO Nestle et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance
H Kobayashi et al.
BLOOD (2005)
Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity
S Yanagita et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Viral and nonviral uses of imiquimod: A review
AK Gupta et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2004)
Bacteriolytic therapy can generate a potent immune response against experimental tumors
N Agrawal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The use of dendritic cells in cancer immunotherapy
G Schuler et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells
C Pasare et al.
SCIENCE (2003)
Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8
H Schaider et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
New aspects of natural-killer-cell surveillance and therapy of cancer
MJ Smyth et al.
NATURE REVIEWS CANCER (2002)
Killing activity of neutrophils is mediated through activation of proteases by K+ flux
EP Reeves et al.
NATURE (2002)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The intriguing role of polymorphonuclear neutrophils in antitumor reactions
E Di Carlo et al.
BLOOD (2001)
The macrophage - a novel system to deliver gene therapy to pathological hypoxia
L Griffiths et al.
GENE THERAPY (2000)